For the quarter ended March 2024, National Health Investors (NHI) reported revenue of $81.51 million, down 1.1% over the same period last year. EPS came in at $1.10, compared to $0.79 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $79.36 million, representing a surprise of +2.71%. The company delivered an EPS surprise of +4.76%, with the consensus EPS estimate being $1.05.While investors closely watch year-over-year changes in headline numbers -- revenue and earning ...

Exhibit 99.1 Contact: John L. Spaid, Chief Financial Officer Phone: (615) 890-9100 NHI Announces First Quarter 2024 Results MURFREESBORO, Tenn. – (Monday, May 6, 2024) National Health Investors, Inc. (NYSE:NHI) announced today its results for the three months ended March 31, 2024. Financial Results and Recent Events • Net income attributable to common stockholders per diluted common share for the three months ended March 31, 2024 was $0.71 compared to $0.79 during the same period in the prior year. • Nation ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period endedMarch 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from_____________ to _____________ Commission File Number 001-10822 National Health Investors, Inc. (Exact name of registrant as specified in its charter) Maryland 62- ...

National Health Investors, Inc. (NYSE:NHI) Q4 2023 Results Conference Call February 21, 2024 11:00 AM ET Company Participants Dana Hambly - Director of Investor Relations Eric Mendelsohn - President and Chief Executive Officer Kevin Pascoe - Chief Investment Officer John Spaid - Chief Financial Officer Conference Call Participants Richard Anderson - Wedbush Omotayo Okusanya - Deutsche Bank Juan Sanabria - BMO Capital Markets Austin Wurschmidt - KeyBanc Capital Markets Operator Greetings, and welcome to the ...

• Rental income recognized from the Company's tenants, including the effects of straight-line lease revenue and property taxes and insurance on leased properties, increased $7.0 million primarily from an increase in pandemic-related rent repayments of approximately $2.6 million and new investments funded since December 2022. The amortization of lease incentives increased by $2.2 million primarily related to a $10.0 million lease incentive paid in February 2023; • Net income attributable to common stockholde ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____________ to _____________ Commission File Number 001-10822 National Health Investors, Inc. (Exact name of registrant as specified in its charter) | Maryland | | ...

National Health Investors, Inc. (NYSE:NHI) Q3 2023 Earnings Conference Call November 8, 2023 11:00 AM ET Company Participants Dana Hambly - Director of Investor Relations Eric Mendelsohn - President & Chief Executive Officer Kevin Pascoe - Chief Investment Officer John Spaid - Chief Financial Officer Conference Call Participants Juan Sanabria - BMO Capital Markets Richard Anderson - Wedbush Austin Wurschmidt - KeyBanc Capital Markets Joe Dickstein - Jefferies Operator Greetings, and welcome to the National ...

| --- | --- | --- | |----------------------------------|-------|-------| | | | | | | | | | National | | | | Health Investors | | | | Investor Update November 7, 2023 | | | | | | | Safe Harbor Statement These slides and other materials we have filed or may file with the Securities and Exchange Commission, as well as information included in oral statements made, or to be made, by our senior management contain forward-looking statements that are based on current expectations, estimates, beliefs and assumptions ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) Commission File Number 001-10822 National Health Investors Inc (Exact name of registrant as specified in its charter) Maryland 62-1470956 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 222 Robert Rose Drive Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an em ...

National Health Investors, Inc. (NYSE:NHI) Q2 2023 Earnings Call Transcript August 9, 2023 12:00 PM ET Company Participants Dana Hambly - Director of IR Eric Mendelsohn - President and CEO Kevin Pascoe - Chief Investment Officer John Spaid - CFO Conference Call Participants Juan Sanabria - BMO Capital Markets Austin Wurschmidt - KeyBanc Capital Markets Operator Greetings, and welcome to the National Health Investors Second Quarter 2023 Earnings Call. [Operator Instructions]. As a reminder, today's call is b ...